Novel diabetes autoantibodies and prediction of type 1 diabetes
- PMID: 23900975
- PMCID: PMC3887556
- DOI: 10.1007/s11892-013-0405-9
Novel diabetes autoantibodies and prediction of type 1 diabetes
Abstract
Autoantibodies are currently the most robust biomarkers of type 1 diabetes and are frequently used to establish entry criteria for the participation of genetically at-risk individuals in secondary prevention/intervention clinical trials. Since their original description almost 40 years ago, considerable efforts have been devoted toward identifying the precise molecular targets that are recognized. Such information can have significant benefit for developing improved metrics for identifying/stratifying of at-risk subjects, developing potential therapeutic targets, and advancing understanding of the pathophysiology of the disease. Currently, four major molecular targets ([pro]insulin, GAD65, IA-2, and ZnT8) have been confirmed, with approximately 94% of all subjects with a clinical diagnosis of type 1 diabetes expressing autoantibodies to at least one of these molecules at clinical onset. In this review, we summarize some of the salient properties of these targets that might contribute to their autoantigenicity and methods that have been used in attempts to identify new components of the humoral autoresponse.
Conflict of interest statement
John C. Hutton received royalties from Kronus for ZnT8 patent #CU1673H
Figures


Similar articles
-
Detection of four diabetes specific autoantibodies in a single radioimmunoassay: an innovative high-throughput approach for autoimmune diabetes screening.Clin Exp Immunol. 2011 Dec;166(3):317-24. doi: 10.1111/j.1365-2249.2011.04479.x. Clin Exp Immunol. 2011. PMID: 22059988 Free PMC article.
-
The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.Autoimmunity. 2011 Aug;44(5):394-405. doi: 10.3109/08916934.2010.540604. Epub 2011 Jan 19. Autoimmunity. 2011. PMID: 21244337
-
Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes Mellitus.Chin Med J (Engl). 2015 Sep 5;128(17):2387-94. doi: 10.4103/0366-6999.163389. Chin Med J (Engl). 2015. PMID: 26315089 Free PMC article. Review.
-
Islet Autoantibodies.Curr Diab Rep. 2016 Jun;16(6):53. doi: 10.1007/s11892-016-0738-2. Curr Diab Rep. 2016. PMID: 27112957 Review.
-
Islet autoantibodies in Latvian subjects with non-insulin-dependent diabetes mellitus: slow-onset type 1 diabetes or polyendocrine autoimmunity?Ann N Y Acad Sci. 2002 Apr;958:259-62. doi: 10.1111/j.1749-6632.2002.tb02982.x. Ann N Y Acad Sci. 2002. PMID: 12021119
Cited by
-
Design and Measurement of Nonislet-Specific Autoantibodies for the Type 1 Diabetes Genetics Consortium Autoantibody Workshop.Diabetes Care. 2015 Oct;38 Suppl 2(Suppl 2):S4-7. doi: 10.2337/dcs15-2002. Diabetes Care. 2015. PMID: 26405071 Free PMC article.
-
A subclass of serum anti-ZnT8 antibodies directed to the surface of live pancreatic β-cells.J Biol Chem. 2018 Jan 12;293(2):579-587. doi: 10.1074/jbc.RA117.000195. Epub 2017 Nov 28. J Biol Chem. 2018. PMID: 29184000 Free PMC article.
-
Down-regulation of the islet-specific zinc transporter-8 (ZnT8) protects human insulinoma cells against inflammatory stress.J Biol Chem. 2019 Nov 8;294(45):16992-17006. doi: 10.1074/jbc.RA119.010937. Epub 2019 Oct 7. J Biol Chem. 2019. PMID: 31591269 Free PMC article.
-
Rapid onset type 1 diabetes with anti-PD-1 directed therapy.Oncotarget. 2020 Jul 14;11(28):2740-2746. doi: 10.18632/oncotarget.27665. eCollection 2020 Jul 14. Oncotarget. 2020. PMID: 32733645 Free PMC article.
-
Pancreas Pathology During the Natural History of Type 1 Diabetes.Curr Diab Rep. 2018 Oct 6;18(11):124. doi: 10.1007/s11892-018-1084-3. Curr Diab Rep. 2018. PMID: 30293191 Review.
References
-
- Rosmalen JG, van Ewijk W, Leenen PJ. T-cell education in autoimmune diabetes: teachers and students. Trends Immunol. 2002;23(1):40–6. - PubMed
-
- Pihoker C, Gilliam l, Hampe C, Lernmark A. Autoantibodies in diabetes. Diabetes. 2005;54:S52–61. - PubMed
-
- Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986;314(21):1360–8. - PubMed
-
- Oling V, Marttila J, Ilonen J, Kwok WW, Nepom G, Knip M, et al. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J Autoimmun. 2005;25(3):235–43. - PubMed
-
- Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes. J Immunol. 2004;172(6):3955–62. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical